Year-end Sale % OFF 
Abstract
Diluted ProHance [Gd(HP-DO3A), Squibb Diagnostics, Princeton, NJ], Sustacal (Meadjohnson, Evansville, IN), a nutritional drink, and a ProHance/Sustacal mixture have been investigated as potential oral contrast agents. At 2 T, T1-weighted (SE 500/20) images demonstrated hyperintense (positive) signal enhancement of rat GI tracts within 10 min after the ingestion of 2.0 mM Gd(HP-DO3A) or 2.0 mM ProHance/Sustacal. T2-weighted (SE 3000/80) images demonstrated hypointense (negative) signal intensity within 10 min after ingestion of 10 mM ProHance. Medical imaging applications of these oral contrast media are feasible.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
